Thursday, November 28, 2019
Hobbit Essays (704 words) - The Hobbit, New Zealand Films
Hobbit Don't judge a book by its cover. This famous phrase can very well be applied to the hobbit a small human like creature that goes along with 13 dwarves and a wizard. The wizard, Gandalf, has total faith in the little hobbit knowing full well that when the time comes he will serve the dwarves quite well. He does this with the help of a ring that makes him invisible. He saves the dwarves from evil spiders that wish to eat them. Uses it to help them escape the clutches of elves that would keep them in their clutches for some time. And to find out the weakness of an evil dragon bent on destroying all those opposing him. Our little hobbit friend is quite an extraordinary little fellow compared to many who probably would have run off the first chance they had, and he proves himself by being brave. He doesn't just think about saving his own hide, but all the dwarves as well. Bilbo Baggins, that is the name of our hero, finds a ring on the floor of a cave; little does he know that this will save he and his friends many a time. Giant spiders capture him and his friends as they are passing through the woods. He first kills the spider that is trying to eat him with his sword. After which he puts on his ring of invisibility and taunts the spiders into following him away from his friends. He then doubles back and cuts his friends out of their respective webs. After that there is a long battle the spiders venom had weakened the dwarves almost to a point that they couldn't stand. So Bilbo had to do most of the fighting. He saved his friends. They get away and all live happily ever after... right? No there will be more danger this is only the beginning. After all of Bilbo's friends are saved elves capture them. It is a good thing Bilbo has his ring on. He follows the elves and gets into the place in which they are captured. He then hatches a plan to save them. He has to steal a key when there is a large banquet happening so as most of the elves are busy, then he must release his friends and stow them away in barrels that are to be sent down the river having been used. Now this sounds like a difficult task but not for our friend Bilbo who is very adept at getting out of tight situations. He releases his friends much to all the elves dismay. Then after all the trouble you would think the rest to be a walk in the park. It is just not that easy. Now they must face a dragon, to claim the treasure they were after from the beginning. Bilbo goes into the dragon's cave silently and invisibly but the dragon has an astute sense of smell! Bilbo has been caught. However not completely caught because the dragon can still not see him. So Bilbo talks the dragon into seeing his underbelly, knowing full well that every dragon has a weak spot on the bottom of their stomachs. The dragon's pretentious nature makes him believe he has no weak spot, so he shows his stomach. There it is a small space of un-armored stomach. He has gotten what he came for and starts to leave the dragon hears this and becomes enraged flying in the direction of the sound and almost burns poor Bilbo alive. But he escapes. The dragon still enraged flies out and wrecks the entrance the dwarves and Bilbo came in after which he goes to try and destroy a town that the dragon concluded had aided Bilbo but word of the dragons weak spot had already been received by one in the village. He takes his arrow aims and fires it straight into the dragon's heart killing it in mid air. Now that the dragon is dead the travelers are free to claim the treasure, but not before a Great War with humans, elves, and dwarves on one side. Wargs (evil wolves), and goblins on the other. The travelers survive most of them anyway, and are finally able to claim the treasure and go home. So "Don't judge a book by its cover." He just might save you over and over again, from evil spiders, elves, and dragons. I recommend this book it is incredibly good and definitely worth reading at the very least.
Sunday, November 24, 2019
Marginal Analysis of Cheating
Marginal Analysis of Cheating In the academic world, tests are used to gauge the level of understanding that has been achieved by the student. As such, failing a test demonstrates a lack of understanding by the students and may lead to many negative repercussions. For this reason, students at all levels strive to ensure that they pass in their tests therefore reaping the benefits of good academic performances. Advertising We will write a custom essay sample on Marginal Analysis of Cheating specifically for you for only $16.05 $11/page Learn More While some students rely on legitimate means such as intensive reading and carrying out exercises prior to the test so as to increase their likelihood of passing, others resort to the illegal means of cheating. This paper shall discuss the best examples of cheating on test and compare their relative costs and benefits. In addition to this, the paper shall try to shed light as to why some students engage in this practice while others do not. Of th e various forms of cheating in existence, arguably the most prevalent one is the use of cheat notes. In this case, students enter into examination areas with written material that may contain answers to the questions that they anticipate. By carefully concealing this material, the studentââ¬â¢s can avoid the detection by supervisors and utilize this material to cheat in exams with favorable results. The major benefit of this method is the accuracy level since the cheating material is obtained from text books, lectures or other decisive authorities on the subject. Students write down material that they find hard to understand and use it in exams setting. This method of cheating is favored by most students since an individual can carry it out on their own without relying on outside help. The major disadvantage of this cheating technique is that there exists physical evidence of the cheating act which may incriminate the student. Another form of cheating involves soliciting answer s from a fellow student who is better in the subject at hand. By pooling their knowledge, students utilizing this method can obtain higher results than they would have if they relied on their own individual efforts. This method is especially invaluable in instances where written evidence of cheating would be undesirable. In cases whereby an exam invigilator is suspicious of cheating, he/she would have a hard time proving it since there is no evidence. Another benefit of this method is that as opposed to the writing of cheat notes method where a student cannot anticipate all questions, in this method, the cheaters can answer a wide array of questions so long as one of them knows the answer.Advertising Looking for essay on business economics? Let's see if we can help you! Get your first paper with 15% OFF Learn More A disadvantage with this method is the lack of clarity since the supposed ââ¬Å"authority on the subjectâ⬠may not know the right answer. S ome exam environments also demand great physical distances between the participants therefore making covert communication hard. Having discussed the various examples of cheating, it would be worthwhile to highlight why some people engage in this degenerative behavior while others do not. Lack of proper preparation for exams leads to some studentââ¬â¢s cheating since they wish to avoid failure. A lack of self confidence may also result in cheating since a student may deem himself/herself incapable of succeeding without external help. As such, most students who perform proper preparation before the exams do not see the need to cheat. Students who have high confidence in their abilities to remember the concepts they have been taught also abstain from cheating. Another group which does not cheat is students who are afraid of the consequences of being caught in the act of cheating. This paper set out to highlight various methods of cheating and outline reasons why some people cheat w hile others do not. From the discussions presented herein, it is evident that the major motivation for cheating is to excel in exams. The paper has suggested that the fear of being caught is what makes some students shy away from cheating or adopt one cheating method and not another. Nevertheless, cheating is illegal and should be avoided by all students by making proper preparations prior to the tests.
Thursday, November 21, 2019
Past and Current Trends in Human Services Assignment
Past and Current Trends in Human Services - Assignment Example Best Practice entails a certain degree of agreement on research-based knowledge and a consultative process of using this knowledge in health care delivery. On the other hand, Evidence-Based Practice involves application of the best-known research evidence when making healthcare-based decisions. Healthcare practitioners use patient preferences and clinical expertise alongside research evidence to provide quality health care (Lippincott, 2007). Integrated Health Care entails the control and delivery of health care services with a combination of curative and preventive services. In this instance, the patients receive care based on their needs over time and across various stages of the health system. The intended outcomes of the trends in Human Services are to ensure effective delivery of human health services. For instance, EBP requires the researcher, client and practitioner to work together to identify circumstances that benefit all parties involved. The approach provides surety that services and treatments, when offered as intended, will produce the most effective outcomes backed up by research. Such trends should be widely disseminated to benefit the greatest number of people. However, some of the unintended consequences are related to the costs incurred in the process. While it is expensive to get quality health care, it is mandatory also to save a life. With the changing trends in the Human Services, networking is essential for all the stakeholders involved. Networking among organizations at state, national and regional levels is essential in building resilience among Human Services providers and also to enable them cope with the fast-changing environment. Networking also provides a forum for information sharing among the various stakeholders. Such networks lead to an improved service delivery in the Human Service sector. State of Michigan.
Wednesday, November 20, 2019
Babcock marine case study Assignment Example | Topics and Well Written Essays - 2250 words
Babcock marine case study - Assignment Example Being the largest warships that the UK has ever commissioned, they are to be built like a giant Lego model and have individual blocks being built at the six shipyards surrounding UK that is before they are transported to Babcockââ¬â¢s Rosyth facility for the final assemble and its integration. If you happen to be in the military or a commercial sea-faring craft, there is an open door for you. A division of the Babcock International, the company provides a wide range of design, support and building services which are inclusive of upgrading, conversion, refitting and maintenance (Brown, 2003). It also offers engineering, as well as, support services to the royal navy. Most of its customers include the government of Canada, New Zealand and Canada. The marine designs the fast ferries, specialist crafts and paramilitary vessels to customers globally. In addition, it offers the water jet propulsion for commercial and military applications, landing craft, workboats, special operations cr afts, design of excluded light in alloy planking in small ship construction and other commercial vessels. Close to that is the ability of the company to provide all spares of procurement services. It supports the third party operators and also the private owners. SWOT analysis Strengths and opportunities The two largest aspects that give the company a reason for existence is the energy and the marine technology. Babcock has provided a platform for the design, integration and also management services in the marine, oil and gas and also in the defense sectors globally. Privileged to have more than 900 engineers and technical support staff, they also have inspired delivery record, proven design and management expertise, focused leadership, it is able to support all its customers on each and every aspect, including the concept of design and modification through the life management together with a safe and environmentally friendly disposal (Kim, 2005). It is the leading UK Engineering su pport services Company, and it is trusted to deliver serious support to the government along with key industry organizations within the globe. The company has proven track record as being the UKââ¬â¢s leader in naval support business that provides its customers with surety and huge confidence regarding its ability to safely and carefully manage and operate some of the countries most core assets together with providence of through-life support in complex programs of national significance (Brown, 2003). Further the submarine partner in the royal navy, the company is the only provider of deep maintenance, infrastructure support and in-service maintenance. The strength of its long term relationship has been portrayed in its involvement in the current and future programmes. It has unique facilities and infrastructure that has enabled the company to undertake about 75% of the UK surface refit refits and also about 50% of fleet maintenance. Managing and also operating two of the three U K naval bases, has enabled Babcock to work successfully with the ministry of Defense over the last ten years and hence delivering considerable cost reductions and further service improvements as part of successful partnering relationship with the Royal Navy and Ministry of Defense. It has unique naval infrastructure across the UK which support complex engineering programmes and at the same time increasing the availability of the customerââ¬â¢
Monday, November 18, 2019
Global Marketing-Strategy and Practice 1 Assignment
Global Marketing-Strategy and Practice 1 - Assignment Example Chiliââ¬â¢s Grill and Bar offers its customers with exotic Mexican and Texan food through a chain of restaurant outlets all over America. The business development strategies consider exploring the UK markets in future. While the restaurant chain has been successful in establishing a strong market presence in the States, the UK market presents new challenges in the form of food culture and consumer habits. The report analyzes the market strategies of the retailer and recommends fresh strategic moves that can help Chiliââ¬â¢s explore the UK markets with specific focus on the city of London. Organizations constantly seek new market opportunities for pursuing its growth objectives. However, international marketing strategies face the primary challenge of entering new markets and this challenge involves the vital decision of where, how, and when to enter. Decisions related to global marketing strategies are often complex considering the wide range of social, economic, political, and technology based factors that impact market viability and approach. Doole and Lowe (2008) in their works on international marketing strategy observed that globalization for firms ââ¬Å"should be the route to maximizing performance by introducing, where possible, standardized marketing programmes and processes, but at the same time, adapting certain operational activities to local needs in order to maximize short term revenue generationâ⬠(p187). The vital strategic consideration while entering a new market is deciding on how and where to adapt as per the needs of the local market segment s. London presents a lucrative market for those in the food business owing to its demand for fast food and restaurant services (Horizon News, 2011). London is a vital business destination attracting large numbers of tourists every day. According to recent reports by PWC (2013) the UK bars and restaurants business is worth over à £40 billion since consumers constantly seek new tastes
Friday, November 15, 2019
The Strategic Priorities Of Glaxosmithkline Plc Economics Essay
The Strategic Priorities Of Glaxosmithkline Plc Economics Essay Part I Pharmaceutical Business Model The business model of companies in pharmaceutical industry for almost two decades is blockbuster model. The blockbusters (drugs that have sales over $ 1 billion per year) have turned out to be a significant factor that driven the pharmaceutical industry from 1990s. There were 65 blockbusters in 2002 increased from only 7 blockbusters in 1990 (Deutsche Bank, 2003 cited in Froud et al, 2006: 169) but, by 2006, the number was raised to 114 (La Merie Business Intelligence, 2007). Exhibit 1 shown that the sales of top ten blockbuster companies from blockbuster drugs alone were accounted larger than one-fourth of world pharmaceutical market in 2006. This blockbuster model was adopted in order to maximize revenue because it was seemed to be possible approach to satisfy high growth expectation of financial community (Business Insight 2003: 10). To conclude, the blockbuster business model was underpinned big pharmaceutical companies success over the past decade. This model is embedded in phar maceutical industry. à ¢Ã¢â ¬Ã ¢ Exhibit 1 Top 10 Blockbuster companies, 2006 Company Sales of Blockbuster US$ billion Number of Blockbuster As % of World Pharmaceutical Market Pfizer 28.8 9 4.48 GlaxoSmithKline 24.3 12 3.78 AstraZeneca 21.1 11 3.28 Sanofi-Aventis 19.9 9 3.09 Johnson Johnson 17.5 8 2.72 Roche 16.1 7 2.50 Amgen 13.4 5 2.08 Merck Co. 12.7 4 1.98 Wyeth 10.0 5 1.56 Eli Lilly 9.4 5 1.46 Total 173.2 75 26.94 Source: La Merie Business Intelligence, 2007 Challenges of Big Pharmaceutical model To begin with, the big pharmaceutical companies such as Pfizer and GSK are over-reliance on the sales of blockbuster drugs. In other words, the companies are generated their main revenue from small number of drugs from their product lines. For example, in 2006, Pfizer had 9 blockbuster drugs which generated almost 60 % of total sales. GSK had 12 blockbuster drugs that contributed 56 % of total sales. Another example, in 2007, we can see that 12 blockbuster drugs of GSK accounted for almost 60 percent of companys total drug sales (see Exhibit 2). Therefore, companies are exposed to high insecurity if they cannot find replacement of products which have equivalent financial size. à ¢Ã¢â ¬Ã ¢ Exhibit 2 GSKs contribution of blockbuster to total drugs sales, 2007 Products Sales US$ million As % of total drugs sales Seretide/Advair 7,001 18.26 Flixotide/Flovent 1,243 3.24 Valtrex 1,869 4.87 Lamictal 2,195 5.72 Imigran/Imitrex 1,371 3.57 Seroxat/Paxil 1,107 2.89 Wellbutrin 1,059 2.76 Coreg 1,175 3.06 Avandia products 2,439 6.36 Augmentin 1,061 2.77 Hepatitis 1,059 2.76 Infanrix/Pediarix 1,087 2.83 Total 22,663 59.1 Source: Company annual report, 2008 Next, the less productive of RD pipeline and increasing cost of RD. There is a downward trend of the number of New Molecular Entities (NMEs) and Biologics License Applications (BLAs). In 1996, there are almost 40 approvals of NMEs and BLAs but, by 2007, the figure was decreased to 18 (Riley 2008). In addition, the cost to develop a drug is ten-fold increase from $138 million in 1975 to $ 1.318 billion in 2006 (PhRMA 2009) (see Exhibit 3). Hence, from the opposite direction of RD cost and RD productivity, we can conclude that the overall efficiency of RD in industry is lower than in the past. Finally, the expiry of patent and the impact of generics. For example, the best selling drug of GSK Seretide/Advair which generated US$ 7,653 million or 17 % of total turnover in 2008 will be expired in 2010 in the US and in 2013 in the EU. In this case, there is a possibility that GSKs turnover might drop sharply after the expiry of Seretide if the company cannot develop product or new source of income to make up for the loss of Seretide/Advair sales. In addition, the increasing in number of patent expiries of blockbusters has a positive impact to the growth in generic market. As exhibit 4 shows, the compound annual growth rate (CAGR) of the global generic market was 16.4% during 2004 to 2007. In contrast, growth rate of overall pharmaceutical industry was at a CAGR of 8.3% in the same span. Another factor driven the growth of generic drugs is the greater attentiveness of payors as a result of current economic recession such as tightened healthcare budget of governments or private p ayors. It is likely that the price of drugs will be pushed down by the greater bargaining power. For instance, Japan had cut the price of drugs on the National Health Insurance (NHI) in 2008 by average 5.2% (Business Insight 2008). All in all, economic and stakeholders in the demanding side of the industry are now shaping the new form of the pharmaceutical market. à ¢Ã¢â ¬Ã ¢ Exhibit 3 Cost of developing new drug, 1975 2006 Source: PhRMA, 2009 à ¢Ã¢â ¬Ã ¢ Exhibit 4 Global Generics Market, 2004 2007 Source: Business Insight, 2008 The Strategic priorities of GlaxoSmithKline PLC In 2008, Andrew Witty was selected to be a CEO of GSK. After two months of being a CEO, he announced new strategy to steer GSK in global pharmaceutical market. There are three new strategic priorities; grow a diversified global business, deliver more products of value and simplify the operating model. This section will discuss how these new strategic a response to problem pharmaceutical business model problem. Grow a Diversified Global Business In this strategic, the company is trying to lessen its risk by widening and balancing its products across all geographic boundaries. In other words, company tries to reduce reliance on blockbuster drugs for companys growth as Witty said The biggest thing Im trying to change is to go from saying its okay to have a blockbuster once every five years to a situation where we are delivering several new products every year (Goodman 2008). As a recession in the USA, it had a huge impact in the US sales which is a main market for company that accounted for 40% of total revenue in 2008. The sales in the US decreased by 4.2% in 2008 compare to 2007 while Europe market and rest of the world market sales were increased by 16.3% and 16.6% respectively (GlaxoSmithKline 2009). Therefore, at this moment, the US market is saturated; company is now focusing on the market which has high growth such as Africa, China and India but also not ignore the US market. It shows that company is adapted to the curr ent market situation. There are many actions that have been taken by the company that response to the business model problems. First, company is focusing on vaccine, biopharma and consumer healthcare which have high potential growth which in turn might create revenue to make up the loss of sales from expired patent blockbusters. Second, fulfill the potential of emerging markets and Japan market. Japan, alone, accounted for 10% of global pharmaceutical market (Medicines Australia 2009) which is the second largest from the US. It is a big market and a high growth market with market value of US$ 68.6 billion in 2008 and sales growth of 17.2% over 2007 (Business Insight 2009). In emerging markets, particularly, the seven pharmerging market including China, Brazil, Mexico, South Korea, India, Turkey and Russia seem to be the major driven of growth in the global pharmaceutical industry (see Exhibit 5). Better approach to generic is driven this growth. It is likely that GSK is now more con centrated on generic drugs, for example, company acquired branded generics from both Bristol-Myers Squibb and UCB as well as formed alliance with South Africas Aspen Pharmacare and Dr Reddys of India (Hirsler, 2009). To conclude, this strategic priority seems to be positive reaction of the company regarding the over-reliance on blockbusters, market decline in the US and the impact of generics as Johnson et al. (2008) suggested that diversification is suitable when current markets saturated while need for more rapid growth. à ¢Ã¢â ¬Ã ¢ Exhibit 5 Sales in 7MM and pharmerging markets ($m), 2003 2007 Markets 2007 CAGR 2003-07 7MM 466,145 5.62% Pharmerging markets 58,652 15.79% 7MM = USA, Japan, France, Italy, Spain, Germany, UK Pharmerging markets = China, Brazil, Mexico, South Korea, India, Turkey and Russia Source: Riley, 2008 Deliver More Products of Value GSK is lack of therapy area diversification and technology concentration. We can see that there are only 6% of biopharma in GSKs pipeline. Moreover, oncology area represented only 1% of GSKs Sales in 2007 while this area had global market growth of 3%. In order to maintain growth in the long term, GSK need to adjust its RD issues (Riley 2008). Therefore, company announced plan as follow. First, company will focused on eight areas of therapy. Second, externalize RD as its take a long time to create and develop by in-house. Third, GSK will create new biopharma and oncology RD unit in China that have lower cost than established in developed countries which in turn help company to control RD budget. Finally, divided RD units into small group and financed dependent upon its performance which in turn will stimulate innovation. To conclude, GSK redefined its RD pipeline and structure is reacted directly to the problems of RD as mentioned previously as well as problem of over-reliance on blo ckbusters. Simplify the Operating Model GSK is trying to reduce cost in running business. First, develop commercial model; for example, integrate the back office finance system into one system across organization. Second, reduce cost in manufacturing. Company has a plan to cut two-third waste in production by 2015 (Jack, 2009a). As a result, company will be able to redeploy the money from cost reduction into investment. Overall, this strategy is not related directly to the problems of business model, however, the amount of reduction in working capital can be put to RD or other investments which might turn to be in form of company growth (Bender and Ward 2009). In conclusion, it is obvious that new strategy of Andrew Witty is reflected directly to the problems of business model which are heavily reliant on blockbusters, RD problem and impact of generic drugs. However, company is likely to put their focus on small molecules which is the core heritage of the company and the existing products as well as diversify its portfolios and adapted itself into recent market environment. Part II Will new strategy succeed? The new strategy of GSK is likely to lead the company to succeed in the future as it is reflected straightforwardly to the problems of business model. Additionally, it is not simple to point out or evaluate the firms performance as Rosenzweig (2007) argued that the success or performance is not totally forced by internal factors; in contrast, it is relative to a company itself and environment as a whole. Therefore, successful of strategy in this paper will be defined as if company can increase its shareholder values in the long term. In addition, how will company succeed will evaluate by if the new strategy will increase value of its shareholder. Rappaport (1998) pointed out that shareholder value can be driven by seven factors; raise sales growth, boost operating profit margin, lessen cash tax rate, reduce incremental investment in capital spending, reduce investment in working capital, increase time period of competitive advantage, and reduce cost of capital. Regarding companys diversified global business strategy; there are many significant improvements as a result of applying this strategy. First, there is sales growth compared with quarter in previous year in every quarter from third quarter of 2008, after announcement of new strategy, in British pound term. Furthermore, GSK had an increasing in third quarter 2009 of sales 19% in Japan, 25% in emerging market, and 8% in consumer products (Jack, 2009b). In first quarter of 2009, company experienced decline in US market by 22% company Overall, this strategy reflects directly with sales volume which leads to growth in sales. Therefore, company increases its shareholder value as it can raise its sales growth. Deliver more products of value; from this strategy, company should be able to create more revenue from its value added activities. From the company financial data comparing nine month of 2008 and 2009, we can see that GSK had an increasing in gross profit and operating profit 16% and 8% respectively (see Exhibit 6). However, gross margin and operating margin were decreased slightly by 0.4% and 2.39% to 74.05% and 29.48% respectively. Therefore, company unable to raise its shareholder value by this strategy as it was failed to increase operating margin. Moreover, company has less efficiency as its return on capital employed (ROCE) was dropped (see Exhibit 6 and 7) from 22.18% in three quarter of 2008 to 19.71% in three quarter of 2009. There is a probability that company is unable to deliver more values from money that put it investment. However, value added activities of this industry is more likely as RD process. It takes long time to get outcome from money that invested today. For example, to evaluate the RD performance, we should not consider only the approval of new drugs only, as it takes 10 15 years to develop a new drug which mentioned in part I but also we need to take in account the drug development in the early phase, this drugs which are in process cannot generate profit for company today. Overall, we can see that in this strategy. The company is unable to enhance in shareholder value as it cannot increase it operating margin. This is mean that at this period of time a company is inefficiency to control their selling, administration and RD expense. The third strategy, simplify the operating model. There is one mission in this strategy that related directly to increase shareholder value which is reducing working capital. As in September 2008, company was able to reduce its working capital by 500 Million GBP, therefore, shareholder value is increasing as money from working capital can be return to shareholder in form of dividend or can reinvest in company at low cost of capital. This strategy should able a company to lower cost of operation, in contrast, exhibit 6 shows that selling and administration expense was increasing by 24% while turnover increased only 16%. It seems that company cannot succeed its goal by this strategy. If we take a look at stock price of company, we can see that price is hit the highest in 52 weeks in December 2009 (see exhibit 8). This can indicate that market gains confidence about the company performance. However, P/E ratio 13.79% of the company as 14 December 2009 is still lower than competitors; Pfizer at 15.19% and Novartis at 16.1%. This can be interpreted that price low of GSK is low than competitors. All in all, despite the confidence of the market about GSK, in my opinion, up to the present moment the new strategy is not successful in term of maximizing its shareholder value. As we can see from the numbers such as ROCE and operating margin that company cannot build up or even maintain these ratios. However, it needs to be seen it long run whether strategy will succeed since only internal factors cannot make company to succeed. (2420 Words) à ¢Ã¢â ¬Ã ¢ Exhibit 6 GSK; Nine Month ended Income Statement, 2008 and 2009 Source: GSK Press Release, 28 October 2009 Available at : www.gsk.com [accessed 13 December 2009] à ¢Ã¢â ¬Ã ¢ Exhibit 7 GSK; Nine Month ended Balance Sheet, 2008 and 2009 Source: GSK Press Release, 28 October 2009 Available at : www.gsk.com [accessed 13 December 2009] à ¢Ã¢â ¬Ã ¢ Exhibit 8 Stock Price of GSK, London Stock Exchange, 2years ended 14 December 2009 Source: http://uk.finance.yahoo.com
Wednesday, November 13, 2019
kamikaze :: essays research papers
During the era of the weak emperor Taisho (1912-26), the political power shifted from the oligarchic clique (genro) to the parliament and the democratic parties. In the First World War, Japan joined the Allied powers, but played only a minor role in fighting German colonial forces in East Asia. At the following Paris Peace Conference of 1919, Japan's proposal of amending a "racial equality clause" to the covenant of the League of Nations was rejected by the United States, Britain and Australia. Arrogance and racial discrimination towards the Japanese had plagued Japanese-Western relations since the forced opening of the country in the 1800s, and were again a major factor for the deterioration of relations in the decades preceeding World War 2. In 1924, for example, the US Congress passed the Exclusion Act that prohibited further immigration from Japan. After WW1, Japan's economical situation worsened. The Great Kanto Earthquake of 1923 and the world wide depression of 1929 intensified the crisis. During the 1930s, the military established almost complete control over the government. Many political enemies were assassinated, and communists persecuted. Indoctrination and censorship in education and media were further intensified. Navy and army officers soon occupied most of the important offices, including the one of the prime minister. Already earlier, Japan followed the example of Western nations and forced China into unequal economical and political treaties. Furthermore, Japan's influence over Manchuria had been steadily growing since the end of the Russo-Japanese war of 1904-05. When the Chinese Nationalists began to seriously challenge Japan's position in Manchuria in 1931, the Kwantung Army (Japanese armed forces in Manchuria) occupied Manchuria. In the following year, "Manchukuo" was declared an independent state, controlled by the Kwantung Army through a puppet government. In the same year, the Japanese air force bombarded Shanghai in order to protect Japanese residents from anti Japanese movements. In 1933, Japan withdrew from the League of Nations since she was heavily criticized for her actions in China. In July 1937, the second Sino-Japanese War broke out. A small incident was soon made into a full scale war by the Kwantung army which acted rather independently from a more moderate government. The Japanese forces succeeded in occupying almost the whole coast of China and committed severe war atrocities on the Chinese population, especially during the fall of the capital Nanking. However, the Chinese government never surrendered completely, and the war continued on a lower scale until 1945.
Subscribe to:
Posts (Atom)